Published: 2017-01-02

A study of the relative bronchodilator responsiveness in smoker asthmatics

Raju CH., Ravindranath M.


Background: Anticholinergic agents established bronchodilator agents which are in use for treatment of asthma but with slow onset and late peak of action. In contrast adrenergic agents are potent bronchodilator with fast action. Beside bronchodilatation they also improve mucociliary transport and reduce release of inflammatory mediators.

Methods: After baseline spirometry at zero hour, sequential doses of salbutamol i.e. 100 micrograms were given every hour to achieve the fullest expression of a neuronal mechanism which was reflected as a plateau on dose response curve, after which the other agent, inhaled ipratropium of dose 80 micrograms was administered. This sequence was reversed on the next visit of the patient with the maximum limit of inhaled salbutamol to be 400 micrograms.

Results: More number of smoker asthmatics showed eosinophil counts less than 350/ than the non-smokers. Only salbutamol showed no significant difference in smokers, while on addition of ipratropium, there was a significant change. But in the non smokers, salbutamol alone showed a marked improvement.

Conclusions: For smoker asthmatics combination therapy is more useful than either agent used alone as both the sympathetic or parasympathetic tone is acting simultaneously.


Bronchodilators, Asthma, Smokers, Salbutamol, Ipratropium

Full Text:



Burney P, Malmberg E, Chinn S, Jarves D, Luczynska C, Lal E. The distribution of total and specific serum IgE in the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1997;99:314-22.

Peat JK, Haby M, Spijker J, Berry G, Woolcock AJ. Prevalence of asthma in adults in Busselton, Western Australia. BMJ. 1992;305:1326-9.

Dubois P, Degrave E, Vandenplas O. Asthma and airway hyperresponsiveness among Belgian conscripts, 1978-91. Thorax. 1998;53:101-5.

Peat JK, Gray EJ, Mellis CM, Leeder SR, Woolcock AJ. Differences in airway responsiveness between children and adults living in the same environment: an epidemiological study in two regions of New South Wales. Eur Respir J. 1994;7:1805-13.

Veale AJ, Peat JK, Tovey ER, Salome CM, Thompson JE, Woolcock AJ. Asthma and atopy in four rural Australian aboriginal communities. Med J Aust. 1996;165:192-6.

Aggarwal AN, Choudhry K, Chhabra SK, D’Souza Ga, Gupta D, Jindal SK, et al. Prevalence and risk factors for Bronchial Asthma in Indian adults: a multicetre study. Indian J Chest Dis Allied Sci. 2006;48:13-22.

Cigarette Smoking and Health: American Thoracic Society. Am J Repir Crit Care Med. 1996;153:861-5.

Jindal SK, Kashyap S, Malik SK. Airway Response to Methacholine Inhalation in Asymptomatic Smokers. Indian J Chest Dis & All Sci. 1985;27:225-9.

Malo JL, Filiatrault S, Martin RR. Bronchial Responsiveness to Inhaled Methacholine in Young Asymptomatic Smokers. J App Physiol. 1982;52:1464-70.

Gerrard JW, Cockcroft DW, Mink JT, Cotton DJ, Poonawala R, Dosman JA. Increased Non Specific Bronchial Reactivity In Cigarette Smokers With Normal Lung Function. Am Rev Respire Dis. 1980;122:577-81.

Mullen JB, Wiggs BR, Wright JR, Hogg JC, Pare PD. Non Specific Airway Reactivity in Cigarette Smokers. Am Rev Respir Dis. 1986;133:120-5.

Nicholas JG, Skorodin MS. Anticholinergic, Antimuscarinic Bronchodilators. Am Rev Respir Dis. 1984;129:856-70.

Mcfadden Jr RE, Chapter 236 Asthma, Harrison’s Principle of Internal Medicine 16th Edition: 1512.

Jindal SK, Kaur SJ. Relative bronchodilatory responsiveness attributable to sympathetic end parasympathetic activity in bronchial asthma. Respiration. 1989;56:16-21.

Grandordy BM, Thomas V, de Lauture D, Marsac J. Cumulative dose response curves for assessing combined effects of salbutamol and ipratropium bromide in chronic asthma. Eur Resp J. 1988;1:531-5.

Gross NJ, Skorodin MS. Role of parasympathetic system in airway obstruction due to emphysema. NEJM.1984;311:421-5.

Barros MJ, Rees PJ. Bronchodilator response to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction. Respir Med. 1990;84:371-5.

Robert AS, Prescott G, Carl A. Cigarette smoking among asthmatics adults presenting to 64 emergency departments. Chest. 2003;123:1472-9.

Plaschke P, Janson C, Norrman E, Bjornsson E, Ellbjar S, Jarvholm B. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Repir Crit Care Med. 2000;162:920-4.

Vesterinen E, Kaprio J, Koskenvuo M. Prospective study of asthma in relation to smoking habits among 14729 adults. Thorax. 1988;43:534-9.

Pedersen B, Dahl R, Karlstrom R, Peterson C, Venge P. Eosinophil and neutrophil activity in asthma in one-year trial with inhaled budesonide. Am J Respir Crit Care Med. 1996;153:1519-29.

Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15 year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339:1194-200.

Apostol G, Jacobs D, Tsai AW, Crow RS, Williams OD, Townsend MC, et al. Early life factors contribute to the decrease in lung function between ages 18 and 40. Am J Respir Crit Care Med. 2002;166:166-72.

James AL, Palmer LJ, Kicic E, Maxwell PS, Lagan SE, Ryan G, et al. Decline in lung function in the busselton health study :the effects of asthma and cigarette smoking. Am J Respir Crit Care Med. 2005;171:109-114.

Wimpe JB, Postma DS, Brderveld N, Alting-Hebing D, van der Mark TW, Koiler GH. Separate and combined effects of corticosteroids and bronchodilators on airflow obstruction and airway hyperresponsiveness in asthma. J Allergy Clin Immunol. 1992;89:679-87.

Brophy C, Ahmed B, Bayston S, Arnold A, McGivern D, Greenstone M. How long should atrovent be given in acute asthma? Thorax. 1998;53:363-7.

Laustiola K, Lassilia R, Kaprio J, Koskenvuo M. Decreased beta-adrenergic receptor density and catecholamine response in male cigarette smokers: a study of monozygotic twin pairs discordant for smoking. Circulation. 1988;78:1234-40.

Sippel JM, Pedula KL, Vollmer WM, Buist AS, Osborne ML. Associations of smoking with hospital-based care and quality of life in patients with obstructive airway disease. Chest. 1999;115: 691-6.

Prescott E, Lange P, Vestbo J. Effect of gender on hospital admissions for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population. Thorax. 1997;52: 287-9.